Difluprednate ophthalmic emulsion 0.05% (Durezol(®)) administered two times daily for managing ocular inflammation and pain following cataract surgery

OBJECTIVE: To evaluate the efficacy and safety of twice-daily difluprednate ophthalmic emulsion 0.05% (Durezol(®)) versus placebo administered before surgery for managing inflammation and pain following cataract extraction. METHODS: Eligible subjects (N = 121) were randomized 2:1 to topical treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Stephen, Lorenz, Douglas, Peace, James, McLeod, Kimberly, Crockett, RS, Vogel, Roger
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938279/
https://www.ncbi.nlm.nih.gov/pubmed/20856594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938279/
https://www.ncbi.nlm.nih.gov/pubmed/20856594

Ejemplares similares